I think it has just got itself in such a tight bind and why the market remains so hesitant. Assuming the standard cash burn of $1.2M a quarter they have 4 months CaB (not attributing todays Undisclosed milestone) and those convertible notes are still standing with the 40% discount which means it is probably going to be incredibly hard for the company to find a reasonable finance option - it's not exactly a mouth watering proposition for anyone to buy on market.
I agree it's good to see Janssen being expanded and reiteration of recent data and "conjugates" slipped in but another 'undisclosed' milestone payment - really ? I still find these things hard to wrap my head around - if the science and recent developments are so ground breaking, why isn't a company the size of Janssen just acquiring the minnow sitting under $10M right now ?
Would of been nice to see Janssen come through with a paragraph praising the science and progress from an external party.
- Forums
- ASX - By Stock
- PYC
- Ann: Janssen Collaboration Expanded
PYC
pyc therapeutics limited
Add to My Watchlist
2.11%
!
$1.39

Ann: Janssen Collaboration Expanded , page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.39 |
Change
-0.030(2.11%) |
Mkt cap ! $828.2M |
Open | High | Low | Value | Volume |
$1.42 | $1.42 | $1.37 | $19.07K | 13.74K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1247 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 13000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5901 | 1.385 |
1 | 839 | 1.380 |
6 | 15865 | 1.370 |
1 | 17650 | 1.360 |
1 | 839 | 1.355 |
Price($) | Vol. | No. |
---|---|---|
1.400 | 2139 | 2 |
1.405 | 1400 | 1 |
1.410 | 7444 | 2 |
1.415 | 917 | 1 |
1.420 | 26097 | 2 |
Last trade - 10.25am 23/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |